Annex D - i+solutions model long-term agreement (LTA) ITB-Iplus/GDF-MED/2023/2

Annex C- List of priority countries for TB medicines registration ITB-Iplus/GDF-MED/2023/2

Annex B - List and technical specifications of products requested ITB-Iplus/GDF-MED/2023/2

Annex A - Financial Bid Response Form ITB-Iplus/GDF-MED/2023/2

ITB-Iplus/GDF-MED/2023/2

Barriers and Facilitators to Implementing a Digital Adherence Technology for Tuberculosis Treatment Supervision in Uganda: Qualitative Study

Leddy A, Ggita J, Berger C, Kityamuwesi A, Sanyu A, Tinka L, Crowder R, Turyahabwe S, Katamba A, Cattamanchi A

Pooling sputum testing to diagnose tuberculosis using xpert MTB/RIF and xpert ultra: a cost-effectiveness analysis

Iem V, Bimba JS, Santos VS, Dominguez J, Creswell J, Somphavong S, Wingfield T, Khan JAM, Cuevas LE.

Key Asks from TB Stakeholders for the UN High-Level Meeting on TB

Sensitivity and specificity of CRP and symptom screening as tuberculosis screening tools among HIV-positive and negative outpatients at a primary healthcare facility in Lusaka, Zambia: a prospective cross-sectional study

Kagujje M, Mwanza W, Somwe P, Chilukutu L, Creswell J, Muyoyeta M.

Pooling sputum samples for Xpert® MTB/RIF and Xpert® Ultra testing for TB diagnosis

Bimba JS, Adekeye OA, Iem V, Eliya TT, Osagie I, Kontogianni K, Edwards T, Dodd J, Squire SB, Creswell J, Cuevas LE.